166 related articles for article (PubMed ID: 2757926)
21. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
22. Fine needle aspiration biopsy diagnosis of metastatic prostate carcinoma to inguinal lymph node.
Rosa M; Chopra HK; Sahoo S
Diagn Cytopathol; 2007 Sep; 35(9):565-7. PubMed ID: 17703448
[TBL] [Abstract][Full Text] [Related]
23. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.
Topf MC; Tuluc M; Harshyne LA; Luginbuhl A
J Immunother Cancer; 2017 Jul; 5(1):60. PubMed ID: 28716144
[TBL] [Abstract][Full Text] [Related]
24. Unusual metastatic spread from carcinoma of the prostate.
Rye BA
Ann Chir Gynaecol; 1988; 77(3):123-4. PubMed ID: 3223731
[TBL] [Abstract][Full Text] [Related]
25. Clinically unrecognised renal carcinoma: aspects of tumor morphology, lymphatic and haematogenous metastatic spread.
Hellsten S; Berge T; Linell F
Br J Urol; 1983 Apr; 55(2):166-70. PubMed ID: 6839087
[TBL] [Abstract][Full Text] [Related]
26. Retained basal cells in metastatic prostate cancer.
Varma M; Alchami FS; Griffiths DF
Histopathology; 2016 Aug; 69(2):338-40. PubMed ID: 26749042
[No Abstract] [Full Text] [Related]
27. [Histomorphologic studies of prostate biopsies, prostatectomy preparations and lymph node metastases in prostatic cancer].
Schubert J; Battke H; Hoffmann L; Raatzsch H
Z Urol Nephrol; 1984 Sep; 77(9):521-8. PubMed ID: 6506894
[TBL] [Abstract][Full Text] [Related]
28. Cervical lymph node metastasis of adenocarcinoma of prostatic origin.
Imenpour H; Anselmi L
Pathologica; 2012 Apr; 104(2):85-9. PubMed ID: 22953506
[TBL] [Abstract][Full Text] [Related]
29. The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma.
Brawn PN; Kuhl D; Speights VO; Johnson CF; Lind M
Arch Pathol Lab Med; 1995 Aug; 119(8):731-3. PubMed ID: 7646331
[TBL] [Abstract][Full Text] [Related]
30. Supraclavicular lymph node: incidence of unsuspected metastatic prostate cancer.
Hematpour K; Bennett CJ; Rogers D; Head CS
Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):872-4. PubMed ID: 16830117
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of poorly differentiated prostatic adenocarcinoma.
El-Mahdi AM; Oliphant LD; Schellhammer PF
Urology; 1983 Jun; 21(6):566-9. PubMed ID: 6868227
[TBL] [Abstract][Full Text] [Related]
32. Metastases to the ureter. Review of the world literature, and three new case reports.
Haddad FS
J Med Liban; 1999; 47(4):265-71. PubMed ID: 10641458
[TBL] [Abstract][Full Text] [Related]
33. Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
Mourra N; Parc Y; McNamara D; Tiret E; Flejou JF; Parc R
Dis Colon Rectum; 2005 Feb; 48(2):384-9. PubMed ID: 15812588
[TBL] [Abstract][Full Text] [Related]
34. SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.
Heebøll S; Borre M; Ottosen PD; Andersen CL; Mansilla F; Dyrskjøt L; Orntoft TF; Tørring N
Histol Histopathol; 2008 Sep; 23(9):1069-76. PubMed ID: 18581278
[TBL] [Abstract][Full Text] [Related]
35. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.
Minardi D; Galosi AB; Giannulis I; Montironi R; Polito M; Muzzonigro G
Scand J Urol Nephrol; 2004; 38(1):19-25. PubMed ID: 15204422
[TBL] [Abstract][Full Text] [Related]
36. [Biological behavior of prostatic carcinoma. II. Clinico-surgical studies on lymphogenic metastasizing of prostatic carcinoma].
Schubert J; Gorski J
Urologe A; 1983 Sep; 22 Suppl():356-9. PubMed ID: 6314623
[TBL] [Abstract][Full Text] [Related]
37. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
38. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
39. [Study of surgically removed pelvic lymph nodes in the staging of prostatic carcinoma].
Hoekstra JW; Schröder FH
Ned Tijdschr Geneeskd; 1982 Dec; 126(50):2291-4. PubMed ID: 7155208
[No Abstract] [Full Text] [Related]
40. Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes.
Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G
BJU Int; 2006 Mar; 97(3):485-91. PubMed ID: 16469013
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
